Finch Therapeutics Group, Inc. (FNCH)
OTCMKTS · Delayed Price · Currency is USD
12.67
-0.03 (-0.24%)
Sep 9, 2025, 1:17 PM EDT
Finch Therapeutics Group Market Cap
Finch Therapeutics Group has a market cap or net worth of $20.35 million as of September 10, 2025. Its market cap has increased by 852.63% in one year.
Market Cap
20.35M
Enterprise Value
33.30M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$12.67
Market Cap Chart
Since March 19, 2021, Finch Therapeutics Group's market cap has decreased from 1.01B to 20.35M, a decrease of -97.98%. That is a compound annual growth rate of -58.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2025 | 20.39M | 12.39% |
| Dec 31, 2024 | 18.15M | 213.02% |
| Dec 29, 2023 | 5.80M | -74.79% |
| Dec 30, 2022 | 22.99M | -95.14% |
| Dec 31, 2021 | 473.36M | -52.91% |
| Mar 19, 2021 | 1.01B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 749.52M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 600.85M |
| CytoDyn | 396.74M |
| Northwest Biotherapeutics | 376.41M |
| American Oncology Network | 353.52M |